<DOC>
	<DOCNO>NCT03036462</DOCNO>
	<brief_summary>The purpose study determine whether intravenous iron supplementation use ferric carboxymaltosis ( FCM ) reduce hospitalisation mortality patient iron deficiency heart failure .</brief_summary>
	<brief_title>Intravenous Iron Patients With Systolic Heart Failure Iron Deficiency Improve Morbidity &amp; Mortality</brief_title>
	<detailed_description>The clinical trial design international , prospective , multi-centre , double-blind , parallel group , randomise , control , interventional trial investigate whether long-term therapy i.v . iron ( ferric carboxymaltosis ) compare placebo reduce rate recurrent heart failure hospitalisation cardiovascular ( CV ) death patient heart failure reduce ejection fraction ( HFrEF ) . I.v . iron administration form ferric carboxymaltosis ( FCM ) carry accord Summary Product Characteristics ( SmPC ) . Bolus administration ( 1000 mg ) follow optional administration 500-1000 mg within first 4 week ( total 2000 mg in-label ) accord approve dosing rule , follow administration 500 mg FCM every 4 month , except haemoglobin &gt; 16.0 g/dL ferritin &gt; 800 Âµg/L . In verum group , patient receive saline administration , iron indicated time visit accord value list . Patients originally assign placebo group receive saline administration visit . In control group i.v . NaCl volume accord dose rule FCM visit administer double-blind manner .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Patients age least 18 year Patients chronic heart failure present least 12 month Confirmed presence iron deficiency Serum haemoglobin 9.5 14.0 g/dL Hypersensitivity active substance , FCM excipients Known serious hypersensitivity parenteral iron product Anaemia attribute iron deficiency , e.g . microcytic anaemia Evidence iron overload disturbance utilisation iron</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>intravenous iron</keyword>
	<keyword>systolic heart failure</keyword>
	<keyword>iron deficiency</keyword>
	<keyword>morbidity</keyword>
	<keyword>mortality</keyword>
</DOC>